Alterity Therapeutics (ATHE) Exchange Rate Effect (2016 - 2020)
Alterity Therapeutics' (ATHE) quarterly Exchange Rate Effect came in at -$172360.6 in Q2 2020, up 39.07% year-on-year from -$123933.5 in Q3 2019, and down 297.37% quarter-over-quarter from $87328.6 in Q4 2019.
Alterity Therapeutics (ATHE) Exchange Rate Effect (2016 - 2020) Analysis & Trends
Alterity Therapeutics' Exchange Rate Effect history runs 5 years deep, the most recent figure standing at -$172360.6 for Q2 2020.
- On a quarterly basis, Exchange Rate Effect rose 39.07% year-over-year to -$172360.6 in Q2 2020; TTM through Jun 2020 was -$203082.4, a 65.29% increase from a year earlier, with the FY2025 full-year figure at -$127045.9, down 174.04% from the prior year.
- Exchange Rate Effect slipped to -$172360.6 in Q2 2020 per ATHE's latest filing, from $87328.6 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $409359.2 in Q4 2016 and bottomed at -$709904.9 in Q2 2016.
- The 5-year median for Exchange Rate Effect is -$85127.6 (2018), against an average of -$121323.2.
- Across the five-year window, Exchange Rate Effect jumped 135.15% in 2018 and plunged 13536.85% in 2019, its largest moves.
- Year by year, Exchange Rate Effect stood at $409359.2 in 2016, then tumbled by 214.58% to -$469062.8 in 2017, then soared by 135.15% to $164855.6 in 2018, then slumped by 47.03% to $87328.6 in 2019, then plunged by 297.37% to -$172360.6 in 2020.
- Per Business Quant, the three latest ATHE Exchange Rate Effect figures stand at -$172360.6 (Q2 2020), $87328.6 (Q4 2019), and -$282906.0 (Q2 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -172,360.55 |
| Jun 30, 2020 | -172,360.55 |
| Dec 31, 2019 | 87,328.62 |
| Dec 31, 2019 | 87,328.62 |
| Jun 30, 2019 | -282,906.04 |
| Jun 30, 2019 | -282,906.04 |
| Dec 31, 2018 | 164,855.57 |
| Dec 31, 2018 | 164,855.57 |
| Jun 30, 2018 | 2,105.45 |
| Jun 30, 2018 | 2,105.45 |
| Dec 31, 2017 | -469,062.76 |
| Dec 31, 2017 | -469,062.76 |
| Dec 31, 2016 | 409,359.19 |
| Dec 31, 2016 | 409,359.19 |
| Jun 30, 2016 | -709,904.92 |
| Jun 30, 2016 | -709,904.92 |